Monday, October 21, 2013

The Idea Of Toxicity With Glioblastoma Tumors

The Idea Of Toxicity With Glioblastoma Tumors

By Robert Sutter


It's apparent that there is much to be said about glioblastoma tumors in terms of how serious they are. They are the ones that a number of studies focus on and it is clear as to why, too. Methods are going to be brought to the forefront and many of them are going to prove to be strong. I have to believe that the strongest on the matter are those which do not bring toxicity into the picture but how exactly can this be done so that it may be able to benefit patients?

First of all, I believe that talking about glioblastomas themselves is something that should be done. It's apparent that they are serious but seeing that they are some of the most common growths in the human body only helps to make them that much more important to look into. Studies will be done and, as a result, research will expand over the course of time. You're going to want to pay attention to a number of different stories, with some of them attaining much more focus than others.

MedPage Today spoke about the matter, saying that the progression of glioblastoma tumors can be changed due to the absence of toxicity. The article said that patients who were part of a particular study received the drug called bevacizumab to start. They were also treated with standard chemoradiation, which is a common method looked at by organizations along the lines of Voices against Brain Cancer. What were the results of this particular study and, just as importantly, did it prove to be useful without having to bring toxicity into account?

For those who believe that bevacizumab should not be put to use, you have to keep in mind that it can prove to be rather useful. After all, it has been put to use in therapies before and it's one that can be utilized in order to help this condition gain even more focus. The article spoke about corticosteroids as well and how they have been reduced as well. Since these can play into inflammation, for example, it's apparent that the use of this drug has shown positives.

It's apparent that there will be many different studies done but how many of them are going to prove to be useful amongst all of them? This is something to take into account since therapies typically utilize toxicity in order to allow progression, which is something that could have adverse effects on patients if they are done enough. The idea of patients being helped without it is something worth noting and it's a note that deserves the respect of researchers who have facilitated such actions.




About the Author:



Share This

No comments:

Post a Comment

Designed By Blogger Templates